Self-administered Blood Collection Devices Help Monitor Chronic Diseases amidst COVID-19 Scare
The concept of self-administered blood collection is becoming increasingly mainstream in the wake of the COVID-19 pandemic. For instance, Tasso Inc.- a medical equipment manufacturer in Seattle, has been successful in acquiring a funding of US$ 17 Mn to innovate in a push-button blood sampling device that does not require any training. Thus, companies in the capillary and venous blood sampling devices market are taking cues from such innovations to increase the availability of home blood testing devices. As such, home-based capillary and venous blood sampling devices are being used by individuals to administer any chronic or infectious diseases, as the COVID-19 scare continues to surge worldwide. This is driving the capillary and venous blood sampling devices market.
With the help of telemedicine, individuals can conduct virtual clinical trials via self-administered blood collection devices.
To know the scope of our report Get a Sample on Capillary and Venous Blood Sampling Devices Market
Small-volume Blood Collection Devices Create Incremental Opportunities for Med-tech Companies
Innovative sample handling and analytical technologies are being used in clinical studies in order to make diagnostic blood testing more accessible and convenient. Hence, companies in the capillary and venous blood sampling devices market are entering into strategic partnerships to improve clinical outcomes. For instance, the medical technology company, BD (Becton, Dickinson and Company), announced collaboration with transformative diagnostic blood testing company Babson Diagnostics to increase the availability of less expensive laboratory testing in a customer-friendly manner.
The development of innovative capillary and venous blood sampling devices is in the pipeline for med-tech companies. The goal is to increase the availability of laboratory-quality diagnostic testing through retail pharmacies. Hence, companies in the capillary and venous blood sampling devices market are increasing their R&D activities to innovate in small-volume blood collection devices that can be made available in urgent care centers and skilled nursing facilities.
Request for Analysis of COVID19 Impact on Capillary and Venous Blood Sampling Devices Market- https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=78279
Push-button Blood Collection Devices Overcome Limitations of Fingersticks
Companies in the capillary and venous blood sampling devices market are developing disposable blood collection devices that use capillary action that help to draw blood from tiny channels. A fingerstick is among the list of popular disposable blood collection devices found to show good results in HIV (Human Immunodeficiency Virus) clinical trials. However, the potential variation between droplets of blood during HIV viral load tests acts as a restraining factor, thus affecting the sales of fingersticks. Hence, companies are overcoming these obstacles by focusing on technologies that collect microliters of capillary blood.
Get a glimpse of the in-depth analysis through our Report Brochure
Seventh Sense Biosystems gained global recognition for its TAP device, which is a novel push-button blood collection device that uses a vacuum chamber to collect up to several microliters of capillary blood. Manufacturers in the capillary and venous blood sampling devices market are increasing efforts to develop devices with large volume capacities.
Enquiry before Buying Capillary and Venous Blood Sampling Devices Market Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=78279
Moisture-tight Designs of Non-biohazardous Devices Improve Patient Outcomes
The demand for non-biohazard devices is surging in the diagnostic testing landscape. Hence, San Francisco-based med-tech company Spot On Sciences has introduced HemaSpot HF, which is an FDA-(Food & Drug Association) pending Class 2 Device, which, after the collection and transportation of blood microsamples becomes non-biohazardous after drying. Such innovations are bolstering the growth of the capillary and venous blood sampling devices market, which is estimated to reach a value of US$ 2.4 Bn by 2030.
Med-tech companies in the capillary and venous blood sampling devices market are increasing their research efforts to introduce unique absorbent collection matrixes in the cartridges of devices to prevent risks of bio-hazardous incidences. They are increasing focus in moisture-tight designs for capillary and venous blood sampling devices with tamper-evident latches so that the sample results remain uncompromised.
More Trending Reports by Transparency Market Research:
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
Contact Us
Rohit Bhisey
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com